CliffBio
small molecule

SOLAGE

MEQUINOL; TRETINOIN

Loss of exclusivity—loss of exclusivity
CompanyAlmirall →See this company's full patent-cliff portfolio

Drug detail

Brand nameSOLAGE
Active ingredientMEQUINOL; TRETINOIN
Strength2%;0.01%
Dosage formSOLUTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalDecember 1999
Marketing statusDISCN

More from Almirall

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

SOLAGE patent cliff — loss of exclusivity — | CliffBio